Finally, most patients were not prescribed novel heart failure drugs, such as an ARNI or SGLT2 inhibitors, further studies are needed to evaluate the effect of these medications on the ventricular arrhythmia events in CRT patients. The gene discussed is SLC5A2; the disease is Ventricular arrhythmia.